HLTRF   $3.2  -3.03% Market Closed

HLS THERAPEUTICS INC
Total Cash 32.52M
totalCashPerShare 1.023
EBITDA 17.30M
Total Debt 83.07M
quickRatio 1.597
currentRatio 2.024
Total Revenue 58.89M
debtToEquity 100.44
Revenue/Share 1.839
ROA -0.028870001
ROE -0.24816999
grossProfits
freeCashflow 20.99M
operatingCashflow 12.40M
earningsGrowth
revenueGrowth -0.116
grossMargins 0.75844
ebitdaMargins 0.29383
operatingMargins -0.13947
profitMargins -0.40905
enterpriseValue 130.04M
forwardPE
floatShares 19.29M
sharesOutstanding 31.79M
sharesShort
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders 0.00%
heldPercentInstitutions 0.65%
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding
bookValue 2.601
Price To Book help_outline 0.96
earningsQuarterlyGrowth
netIncomeToCommon -24.09M
trailingEps -0.75%
forwardEps
enterpriseToEbitda 7.51
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 12
lastUpdated Nov. 6, 2024, 7:35 p.m.